Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 6Phase 3 3Phase 4 2Phase 2/3 2Phase 1 2Phase EARLY_PHASE1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 522Leukemia, Myeloid, Acute 499Neoplasms 380Carcinoma, Non-Small-Cell Lung 380Pancreatic Neoplasms 329Precursor Cell Lymphoblastic Leukemia-Lymphoma 318Multiple Myeloma 312Glioblastoma 311Melanoma 309Prostatic Neoplasms 293Leukemia 288Neoplasm Metastasis 284Brain Neoplasms 275Lymphoma 271Lung Neoplasms 269Recurrence 266Ovarian Neoplasms 247Colorectal Neoplasms 246Lymphoma, Non-Hodgkin 242Leukemia, Lymphocytic, Chronic, B-Cell 231Myelodysplastic Syndromes 208Glioma 208Lymphoma, Large B-Cell, Diffuse 186Carcinoma, Hepatocellular 173Lymphoma, Follicular 167Head and Neck Neoplasms 161Hodgkin Disease 160Lymphoma, Mantle-Cell 155Burkitt Lymphoma 154Sarcoma 150

Interventions

Timolol 1Population Groups 1Lasers, Dye 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Hemangioma, Capillary × Clear all
NCT00573729 2022-10-20

Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks: Comparison of 577 nm Versus 595 nm Wavelengths

University of California, Irvine

Phase 1 Completed
56 enrolled

Hemangioma, Capillary, Vascular Malformations

NCT01434849 2016-11-15

TiPPIH

The University of Texas Health Science Center at San Antonio

Phase 1 Terminated
26 enrolled

Hemangioma, Capillary, Premature Birth

Data powered by HemOnc (CC BY 4.0) Colophon âš¡